9.79% 0.0401

Gt Biopharma Inc (GTBP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Gt Biopharma Inc Azioni (GTBP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Selling, General, and Administrative	53.53% 4.219	2.748	1.15	0.833	2.297
Operating Income/Loss	65.43% -5.595	-3.382	-1.513	-1.932	-3.604
Nonoperating Income/Loss	100.97% -0.113	11.68	-28.66	1.156	0.193
Income/Loss From Continuing Operations Before Tax	168.78% -5.708	8.299	-30.17	-0.80	-3.411
Income/Loss From Continuing Operations After Tax	168.78% -5.708	8.299	-30.17	-0.80	-3.411
Net Income/Loss	168.78% -5.708	8.299	-30.17	-0.80	-3.411
Preferred Stock Dividends And Other Adjustments	56.97% 1.808	4.202	0.085	-	-
Attributable To Noncontrolling Interest	-	-	-	-0.024	-
Basic Average Shares	36.86% 2.4882	3.9407	2.7718	2.3451	2.2343
Diluted Average Shares	36.86% 2.4882	3.9407	2.7718	2.3451	2.2343
Basic Earnings Per Share	113.46% 2.22	1.04	-10.92	-0.33	-1.53
Diluted Earnings Per Share	113.46% 2.22	1.04	-10.92	-0.33	-1.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	56.97% 1.808	4.202	0.085	-	-

RVMD

$99.12

0.49%

ROIV

$28.33

1.76%

RPRX

$48.57

0.16%

BNTX

$91.18

1.97%

ONC

$310.79

0.76%

INSM

$162.43

1.47%